[1] |
ZHAN Guohua, HU Jiaxin, PAN Lixin, WANG Qiuyan, XIANG Bangde.
Characteristics of immune microenvironment of TP53 mutant HBV-related hepatocellular carcinoma revealed by CyTOF
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 492-499.
|
[2] |
WANG Wei, ZHANG Yan, WEI Chong, ZHAO Danqing, ZHANG Wei, ZHOU Daobin .
Clinical features of splenic marginal zone lymphoma with MYD88 L265P mutation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 277-282.
|
[3] |
LIU Yang, GUO Shanshan, LIU Manling, LI Yijie, JIA Yongfeng, GUO Xu.
Detection of mitochondrial DNA mutations in
hepatocellular carcinoma by targeted next generation sequencing
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 480-484.
|
[4] |
LI Hong, WU Linghong, DENG Wei, HUANG Youquan, HAN Xiao, LIAN Shanxiong, HUANG Tianren.
Analysis of HBV S gene mutation in HBV-related hepatocellular carcinoma tissues and pericarcinoma liver tissues in Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 382-386.
|
[5] |
MAO Xinru, LIU Wenbin, CAO Guangwen.
Genomic analysis revealed new prognosis signature in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(2): 143-150.
|
[6] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|
[7] |
Liu Lingfeng,Geng Yichao,OuYang Weiwei,Ma Zhu,Li Qingsong,Li Mei, Wang Yu,Luo Daxian,Yang Wengang,Su Shengfa,He Zhixu,Lu bing.
Comparison of clinical efficacy of cisplatin combined with pemetrexed or docetaxel in stage Ⅳ lung adenocarcinoma based on propensity score matching
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 290-294.
|
[8] |
Tan Baogao,Liu Biao.
The value of 3.0T MR arterial spin labeling in the diagnosis of early-stage primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 310-313.
|
[9] |
Wang Jianwu, Yu Xiangyuan, Wang Qianqian, Qin Linyuan, Bei Chunhua,Tan Shengkui, He Songqing, Tang Bo, Liao Weijia, Yu Hongping.
Single nucleotide polymorphisms in DNA repair gene RAD52 miRNA target sequence and susceptibility to hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 99-104.
|
[10] |
Gan Yingyuan,Deng Wei,Huang Tianren,Wu Hanghang,Huang Yueying,Zhang Yuli.
A case-control study of association between hepatitis B virus S gene mutation and primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(3): 181-185.
|
[11] |
Wei Feifei, Liao Yan, Zhao Ruiqiang, Wang Hongxue, Xie Yu'an.
ITGβ1 polymorphism and genetic susceptibility to hepatocellular carcinoma in families from the Zhuang community in Fusui County, Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 273-277.
|
[12] |
Bai,Qi Lunan,Chen Jie,Ye Jiazhou,Wu Feixiang,Peng Tao,Li Lequn.
Significance of p53 gene mutation and expression in human primary hepatocellular carcinoma in the presence of hepatitis B virus and aflatoxin B1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(1): 1-6.
|
[13] |
YIN Xue,ZHU Xiaodong,LIANG Xia,QU Song,LI Ye,LI Ling,ZHAO Wei.
Effects of different doses of ionizing radiation on DNA damage and apoptosis of breast cancer cells with and without BRCA mutations
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(1): 23-27.
|
[14] |
ZHANG Shi-jie,MA Yi-long,KANG Ping,MENG Zhi-bin,LI Zhi-kun,OU Sheng-qiu,QI Feng,ZHAO Chang.
Comparing the therapeutic efficacy of TACE combined with psychro-circulation percutaneous microwave coagulation therapy or radioactive 125I particle implantation to treat large primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 246-249.
|
[15] |
YE Xin-ping,PENG Tao,SHANG Li-ming,PENG Ning,LI Jia-mei,QIN Xiao,SU Zhi-xiong.
Clinical efficacy and toxicity of TACE combined with sorafenib in advanced hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 242-245.
|